Benchmark Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$960K |
| 2 |
Medtronic
MDT
|
+$955K |
| 3 |
Walt Disney
DIS
|
+$627K |
| 4 |
CORR
CorEnergy Infrastructure Trust, Inc.
CORR
|
+$603K |
| 5 |
Johnson & Johnson
JNJ
|
+$573K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.23M |
| 2 |
Merck
MRK
|
+$1.04M |
| 3 |
General Motors
GM
|
+$1.02M |
| 4 |
iShares Mortgage Real Estate ETF
REM
|
+$990K |
| 5 |
AbbVie
ABBV
|
+$982K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.53% |
| 2 | Healthcare | 15.93% |
| 3 | Real Estate | 15.05% |
| 4 | Financials | 12.27% |
| 5 | Technology | 12.26% |
Similar funds
Benchmark Capital Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Benchmark Capital Advisors held 151 positions worth $128M, down 0.47% from $129M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Benchmark Capital Advisors withdrew a net $4.31M in Q4 2017, closing 14 positions and reducing 61 holdings. Its most notable exit was Procter & Gamble, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Benchmark Capital Advisors opened a new position in Intel worth $1.02M.
- Benchmark Capital Advisors's largest Q4 2017 buy was Intel: 22,000 shares worth $1.02M.
- Benchmark Capital Advisors added most to Walt Disney in Q4 2017, an estimated $627K increase.
- Benchmark Capital Advisors's biggest Q4 2017 reduction was General Motors, cutting an estimated $1.02M.
- Benchmark Capital Advisors fully exited Procter & Gamble in Q4 2017, selling an estimated $1.23M.
- Benchmark Capital Advisors's ten largest holdings make up 30% of its $128M portfolio in Q4 2017.
- Benchmark Capital Advisors opened 9 new positions and closed 14 in Q4 2017.
- Benchmark Capital Advisors's portfolio value fell 0.47% quarter-over-quarter to $128M.
Based on Benchmark Capital Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.